• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    156.63 Up 6.49(4.32%) Dec 19, 4:00PM EST
    |After Hours : 156.80 Up 0.17 (0.11%) Dec 19, 7:47PM EST
    Add to Portfolio
    Prev Close:150.14
    Open:149.41
    Bid:N/A
    Ask:472.23 x 100
    1y Target Est:427.50
    Beta:-6.09
    Earnings Date:Mar 12 - Mar 16 (Est.)
    Day's Range:148.41 - 158.18
    52wk Range:61.95 - 497.00
    Volume:1,240,328
    Avg Vol (3m):563,892
    Market Cap:3.35B
    P/E (ttm):N/A
    EPS (ttm):-12.86
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ICPTUp 4.32%3.35B
    AZNDown 0.58%90.54B
    SLXPDown 1.06%7.47B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,884.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-14.47
    Quarterly EPS Est (Dec-14) :-1.66
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):2.66

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback